Microvascular smooth muscle and endothelium

Microvascular smooth muscle and endothelium refers to the integrated cellular system of the smallest blood vessels, including arterioles, capillaries, and venules. The endothelium acts as a dynamic interface between blood and tissues, regulating vascular tone, permeability, and inflammation through the release of factors like nitric oxide and endothelin-1 [1][2]. Microvascular smooth muscle cells and pericytes provide structural support and control vessel diameter, thereby determining local blood flow and systemic vascular resistance [3]. This system is not a single molecular target but a physiological environment containing numerous drug targets such as ion channels, G protein-coupled receptors, and enzymes. Dysfunction within this unit is central to the progression of cardiovascular diseases, diabetic complications, and inflammatory states [4]. Pharmacological interventions targeting this system aim to modulate vasodilation, stabilize the endothelial barrier, or inhibit pathological angiogenesis. [1] https://www.ncbi.nlm.nih.gov/books/NBK544305/ [2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311236/ [3] https://www.ncbi.nlm.nih.gov/books/NBK559225/ [4] https://pubmed.ncbi.nlm.nih.gov/28837318/

Other names

MicrovasculatureMicrovascular bedSmall vessel wallMicrovascular unit

Drugs act on this system by modulating various molecular pathways, such as activating the nitric oxide-cGMP pathway for vasodilation, blocking calcium channels in smooth muscle, or inhibiting vascular endothelial growth factor (VEGF) signaling to control permeability and vessel growth.